Events

Algomedix has been selected to participate in the Bio-Japan 2023 meeting: Asia’s Premier Partnering Event for the Global Biotechnology Industry, October 11th – 13th, 2023, at the Pacifico, Yokohama, Japan. Algomedix is attending as part of the Biocom California Pavilion.

Algomedix will present at the Link-J Global Life Science Session to be held at 16:00 on October 10^th, 2023, at Nihonbashi, Tokyo, Japan.

Algomedix will be attending and holding partnering meetings at Biocom’s Annual Global Life Science Partnering Conference, February 28^th – March 2^nd, 2023 in San Diego, California.

Algomedix participated in IASP 2022 World Congress on Pain International meeting, which was held September 19^th – 23^rd , Metro Toronto Convention Center, Toronto, Canada.

Algomedix will be attending and holding partnering meetings at Biocom’s Annual Global Life Science Partnering Conference, February 22^nd -24^th, 2022 in San Diego, California.

Algomedix has been selected to participate in the Bio-Japan 2021 meeting: Asia’s Premier Partnering Event for the Global Biotechnology Industry, October 13th – 15th, 2021, at the Pacifico, Yokohama, Japan. Algomedix is attending as part of the Biocom California Pavilion.

Algomedix will be available for partnering discussions from October 15^th – November 15^th, 2021 via online meetings. Please visit the following link for more information.

https://jcd-expo.jp/en/digital-event-Biocom.html

Algomedix participated in Bio Korea 2021 International meeting, which was being held from June 9^th – 11^th; Onsite, and June 6^th  – 21^st; Online 2021 at CoEx Exhibition Center, Seoul, South Korea.

Algomedix has been selected to participate in the meeting: Bio Asia – Taiwan 2020, which is being held from July 22^nd – 26^th,  2020 at Taipei Nangang Exhibition Hall, Taipei, Taiwan. Please meet us at Booth No. R913 at the Washington State Trade and Investment Office.

Algomedix will be presenting scientific results at the Experimental Biology, 2020, conference which is being held from April 4^th – 7^th, 2020 in San Diego, California.

Algomedix will be present on ALGX-XC20, a Novel Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonist Attenuates Joint Pain and Articular Cartilage Damage in an Osteoarthritis Rat Model on April 6^th, 2020 from 4:45 PM – 6:00 PM, at Notable Platform Presentations in Drug Discovery and Development, San Diego Convention Center.

In addition, Algomedix will be presenting on Novel TRPA1 Antagonists are Multimodal Blockers of Human TRPA1 Channels: Drug Candidates for Treatment of Familial Episodic Pain Syndrome (FEPS) on April 7^th, 2020 at the San Diego Convention Center.

Algomedix will be attending and holding partnering meetings at Biocom’s 10^th Annual Global Life Science Partnering Conference, February 25^th-27^th, 2020 in La Jolla, California.